![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
Press Releases
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organisations to make...
Clinical Trials
Abivax gets approval to conduct Covid-19 trial in France
Biotechnology company Abivax has secured approval from France’s National Agency for the Safety of Medicines (ANSM) and French Ethics Committee (CPP) to conduct a...
IT & Data Management
Indica Labs and Octo launch COVID digital pathology repository to support the fight against COVID-19
Indica Labs, a leading provider of computational pathology software, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased...
Press Releases
Covis Pharma begins phase 3 study of asthma drug, Alvesco to treat COVID-19
Covis Pharma announced the initiation of a phase 3 clinical study to assess the safety and efficacy of its asthma drug Alvesco (ciclesonide) in...
News
Parexel, ACRO Joins to Help Administer and Oversee COVID-19 Testing in UK
Parexel announced the deployment of nearly 30 employee volunteers to help administer and oversee COVID-19 testing across the UK in partnership with the Association...
Press Releases
Leinco Announces Development of Immunodiagnostic Test for COVID-19
Leinco Technologies announced an agreement with Vanderbilt University Medical Center (VUMC) to scale up production of its most promising antibodies for development of a...
News
Cellect Biotechnologys ApoGraft to Empower Cellular Treatment of COVID-19 Related Pulmonary Diseases
Cellect Biotechnology Ltd., a developer of innovative technology which enables the functional selection of stem cells, announced that it has signed a development agreement...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read